REVEALED: Diabetes news topic | Vintage Vibes

Blood sugar spikes: what actually works to manage them

Blood sugar, also called blood glucose, rises after eating. Seeing that rise on a wearable monitor can make an ordinary meal look worrying. But a higher reading after lunch does not, by itself, mean that something has gone wrong.

The Conversation · 8h ago

For diabetes patients, stopping GLP-1 drugs linked to doubled risk of heart attack, stroke, death

People with type 2 diabetes who stopped GLP-1 treatment had twice the risk of heart attack, stroke or death than those who continued, according to a new study.

Euronews · 14h ago

Experimental Obesity Drug Survodutide Did Not Raise Heart Attack or Stroke Risk in 5,530-Patient Safety Trial

A large trial found that experimental obesity drug survodutide did not increase major cardiovascular risks, but it has not been shown to protect the heart and caused frequent digestive side effects.

Medical Daily · 18h ago

One CRISPR Infusion Cut Triglycerides 63% in 10 Adults With Diabetes and Severe Levels in Small Early Trial

A single experimental CTX310 infusion lowered triglycerides by 63% after 30 days in 10 adults with severe hypertriglyceridemia, though longer and larger studies are needed.

Medical Daily · Nov 10

Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

GLP-1 products such as Ozempic and Mounjaro spread but many in poorer countries struggle to get basic diabetes treatment

The Guardian - UK · Nov 10

New study uncovers little-known risk of stopping weight-loss injections

The findings relate to a study on type 2 diabetics with no history of heart disease

The Independent UK · Nov 10

What Is Prediabetes and Can It Be Reversed?

Your blood sugar levels could be higher than normal even if you feel completely healthy. You may not experience unusual thirst, frequent urination or tiredness, yet your body could already be showing an early warning sign of diabetes. This condition is called prediabetes. The good news is that it does…

MyLifeXP · Nov 10

FDA adds rare vision-loss warning to popular GLP-1 drugs

The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with popular drugs used for weight loss and diabetes, such as Ozempic

The Independent UK · Nov 9

Ozempic Zepbound eye risk warnings: Diabetes, weight-loss drugs Novo Nordisk's Ozempic, Wegovy, Eli Lilly's Mounjaro, Zepbound pose potential threat to eye, sudden vision loss, warns US FDA

Eli Lilly's Mounjaro and Zepbound and Novo Nordisk's Ozempic and Wegovy were under scanner of United States Food and Drug Administration (US FDA).

The Economic Times · Nov 9

Nick Jonas Makes Heartbreaking Confession About Diabetes After 21 Years: 'Part of Me Resents You'

Nick Jonas has described the emotional strain of managing type 1 diabetes for 21 years, saying he sometimes resents the condition while using his experience to support others.

International Business Times UK · Nov 9